Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration-resistant prostate cancer: Real-world experience in the Southeast Asian cohort

© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. It is of much interest to understand the efficacy of abiraterone acetate (AA) in routine clinical practice. We assessed the clinical outcome of AA in patients with metastatic castration-resistant prostate cancer (mCRPC) an...

Full description

Saved in:
Bibliographic Details
Main Authors: Jasmine Lim, Akara Amantakul, Nisha Shariff, Bannakij Lojanapiwat, Adlinda Alip, Teng Aik Ong, Shankaran Thevarajah, Firdaus Ahmayuddin, Adeline Mathew, Supon Sriplakich, Jaraspong Vuthiwong, Flora Li Tze Chong, Marniza Saad
Format: Journal
Published: 2020
Subjects:
Biochemistry, Genetics and Molecular Biology
Medicine
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085092715&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70213
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085092715&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70213

Similar Items